Evidence map›Paper›PMID 31776738›Full record

ArticleWorld journal of urology2021

How to implement the requirements of a quality assurance system for prostate cancer.

Barbara Noris Chiorda, Fabiana Zollo, Tiziana Magnani, Fabio Badenchini, Lucia Gatto, Melanie Claps, Alberto Macchi, Laure Andreoli, Nicola Nicolai, Sergio Villa and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Barbara Noris ChiordaDivision of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Fabiana ZolloProstate Cancer Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Tiziana MagnaniProstate Cancer Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. tiziana.magnani@istitutotumori.mi.it.ORCID http://orcid.org/0000-0001-6422-9072
Fabio BadenchiniProstate Cancer Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Lucia GattoProstate Cancer Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Melanie ClapsProstate Cancer Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Alberto MacchiProstate Cancer Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Laure AndreoliDivision of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Nicola NicolaiProstate Cancer Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Sergio VillaDivision of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Riccardo ValdagniDivision of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn 2003, the German Cancer Society (Deutsche Krebsgesellschaft, DKG) launched a certification program aimed at improving the quality of cancer care. The purpose of this article is to describe the experience of the Prostate Cancer Unit (PCU) at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, in the process towards DKG certification.

methodsIn 2018, PCU decided to apply for certification by adopting DKG catalogue of requirements (CoR) and quality indicators. A multiprofessional working group was established with the aim of acting the necessary steps to meet DKG standards.

resultsOur organizational setting (procedures, personnel) and activities were accurately analyzed, thus outlining strengths and weaknesses, and modified to comply with DKG CoR and indicators. As examples, (1) a quality management plan was developed; (2) measures were taken to strengthen the surgical expertise; (3) cases evaluated in weekly tumor boards were expanded to include surgical cases with pathological risk factors, metastatic, relapsed and castration-resistant patients; (4) a survey was added to the patient-dedicated initiatives already scheduled; (5) the TuDoc software became the tool to register all new cases of prostate cancer patients referred to PCU.

conclusionsThe process of certification requires many efforts but represents a unique opportunity of improving quality of care of prostate cancer patients, making it comparable on an international scale.

Indexed as

AgedAged, 80 and overCertificationHumansMaleMiddle AgedProstatic NeoplasmsQuality Assurance, Health CareCertificationMultidisciplinarityProstate cancerQuality of care

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.